{Reference Type}: Letter
{Title}: Reply to: "Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed".
{Author}: Zeng ZX;Wu JY;Zhuang SW;Yan ML;
{Journal}: Hepatol Int
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 8
{Factor}: 9.029
{DOI}: 10.1007/s12072-024-10682-6